These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3038160

  • 21. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF).
    Yasaka T, Boxer LA, Baehner RL.
    J Immunol; 1982 May; 128(5):1939-44. PubMed ID: 6278021
    [Abstract] [Full Text] [Related]

  • 22. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
    Rossi AG, MacIntyre DE, Jones CJ, McMillan RM.
    J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
    [Abstract] [Full Text] [Related]

  • 23. A sensitive and specific radioimmunoassay for platelet-activating factor.
    Wang C, Tai HH.
    Lipids; 1992 Mar; 27(3):206-8. PubMed ID: 1522765
    [Abstract] [Full Text] [Related]

  • 24. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C, Mantovani A.
    J Exp Med; 1995 Jun 01; 181(6):2181-6. PubMed ID: 7760005
    [Abstract] [Full Text] [Related]

  • 25. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
    Stewart AG, Harris T, De Nichilo M, Lopez AF.
    Immunology; 1991 Feb 01; 72(2):206-12. PubMed ID: 1849872
    [Abstract] [Full Text] [Related]

  • 26. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
    Bauldry SA, McCall CE, Cousart SL, Bass DA.
    J Immunol; 1991 Feb 15; 146(4):1277-85. PubMed ID: 1846897
    [Abstract] [Full Text] [Related]

  • 27. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
    Stewart AG, Harris T.
    Immunology; 1993 Jan 15; 78(1):152-8. PubMed ID: 8382188
    [Abstract] [Full Text] [Related]

  • 28. Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release.
    Barnett CC, Moore EE, Partrick DA, Silliman CC.
    J Surg Res; 1997 Jul 01; 70(2):166-70. PubMed ID: 9245567
    [Abstract] [Full Text] [Related]

  • 29. Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling.
    Ciesla DJ, Moore EE, Gonzalez RJ, Biffl WL, Silliman CC.
    Shock; 2000 Sep 01; 14(3):265-9; discussion 269-70. PubMed ID: 11028541
    [Abstract] [Full Text] [Related]

  • 30. Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes.
    Aratani H, Nishida Y, Terasawa M, Maruyama Y.
    Jpn J Pharmacol; 1988 Jun 01; 47(2):200-3. PubMed ID: 2848961
    [Abstract] [Full Text] [Related]

  • 31. Arachidonic acid release and platelet-activating factor formation by staurosporine in human neutrophils challenged with n-formyl peptide.
    Müller S, Nigam S.
    Eur J Pharmacol; 1992 Aug 06; 218(2-3):251-8. PubMed ID: 1330596
    [Abstract] [Full Text] [Related]

  • 32. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K, Grünbaum L, Seifert R.
    J Immunol; 1991 Sep 15; 147(6):1940-6. PubMed ID: 1653806
    [Abstract] [Full Text] [Related]

  • 33. C2-ceramide primes specifically for the superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils.
    Richard A, Bourgoin S, Naccache PH, L'Heureux GP, Krump E, McColl SR, Pelletier G.
    Biochim Biophys Acta; 1996 Jan 19; 1299(2):259-66. PubMed ID: 8555272
    [Abstract] [Full Text] [Related]

  • 34. Differential effects of platelet-activating factor on superoxide anion production in human eosinophils and neutrophils.
    Mabuchi K, Sugiura T, Ojima-Uchiyama A, Masuzawa Y, Waku K.
    Biochem Int; 1992 May 19; 26(6):1105-13. PubMed ID: 1321621
    [Abstract] [Full Text] [Related]

  • 35. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils.
    Bauldry SA, Wykle RL, Bass DA.
    Biochim Biophys Acta; 1991 Jul 09; 1084(2):178-84. PubMed ID: 1854803
    [Abstract] [Full Text] [Related]

  • 36. Thrombin-treated endothelium primes neutrophil functions: inhibition by platelet-activating factor receptor antagonists.
    Vercellotti GM, Wickham NW, Gustafson KS, Yin HQ, Hebert M, Jacob HS.
    J Leukoc Biol; 1989 Jun 09; 45(6):483-90. PubMed ID: 2542422
    [Abstract] [Full Text] [Related]

  • 37. Blood transfusion and the two-insult model of post-injury multiple organ failure.
    Aiboshi J, Moore EE, Ciesla DJ, Silliman CC.
    Shock; 2001 Apr 09; 15(4):302-6. PubMed ID: 11303730
    [Abstract] [Full Text] [Related]

  • 38. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
    Fletcher MP, Stahl GL, Longhurst JC.
    J Leukoc Biol; 1990 Apr 09; 47(4):355-65. PubMed ID: 2108228
    [Abstract] [Full Text] [Related]

  • 39. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
    Radhika V, Thennarasu S, Naik NR, Kumar A, Advani SH, Bhisey AN.
    Am J Hematol; 1996 Jul 09; 52(3):155-64. PubMed ID: 8756080
    [Abstract] [Full Text] [Related]

  • 40. Simultaneous recording of calcium transients and reactive oxygen intermediates of human polymorphonuclear granulocytes in response to formyl-Met-Leu-Phe and the environmental agent sulfite.
    Grundler W, Dirscherl P, Beck-Speier I, Beisker W, Stampfl A, Zimmermann I, Maier K.
    Cytometry; 2000 Jul 01; 40(3):219-29. PubMed ID: 10878565
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.